PDL1 EXPRESSION INDUCTION AGENT AND IMMUNE INHIBITOR

摘要

To provide a novel PDL1 expression induction agent, and a novel immune inhibitor having a different action mechanism from the conventional immune inhibitors.SOLUTION: The present invention provides a PDL1 expression induction agent having entecavir, tenofovir or adefovir as an active ingredient, and an immune inhibitor having entecavir, tenofovir or adefovir as an active ingredient.SELECTED DRAWING: None